RT Journal Article
SR Electronic
T1 A 515,579-Genome Reference Panel Improves Rare-Variant Imputation Across Multiple Underrepresented Populations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2026.08.25.26361247
DO 10.64898/2026.08.25.26361247
A1 Ivankovic, Franjo
A1 Ko, Arthur
A1 Aster, M. Morgan
A1 Balaconis, Mary K
A1 Banks, Eric
A1 Bemis, Matthew
A1 Cibulskis, Kristian R
A1 Degatano, Kylee
A1 Gauthier, Laura D
A1 Grant, George
A1 Hatcher, Aaron
A1 Kachulis, Christopher
A1 Karczewski, Konrad J
A1 Labrecque, Sofia M
A1 Lawson, Jonathan
A1 Liao, Calwing
A1 Magner, Ricky
A1 Munshi, Ruchi
A1 Schatz, Michael C
A1 Schultz, Patrick M
A1 Shah, Saloni P
A1 Sheets, Elizabeth A
A1 Tibbetts, Kathleen
A1 Vernest, Kyle A
A1 Ye, Robert
A1 Gabriel, Stacey
A1 Lennon, Niall J
A1 Neale, Benjamin M
A1 Browning, Brian L
A1 Lichtenstein, Lee T
YR 2026
UL http://medrxiv.org/content/early/2026/08/31/2026.08.25.26361247.abstract
AB Genotype imputation remains essential for large-scale human genetics studies, but its performance is limited by the size and ancestral diversity of available reference panels, reducing accuracy for rare variants and underrepresented populations. Here, we present a cloud-based imputation service built on a multi-ancestry reference panel derived from 515,579 jointly phased genomes from the All of Us (N=414,830) and National Human Genome Research Institute’s Analysis, Visualization, and Informatics Lab-space (AnVIL, N=100,749) datasets. The All of Us + AnVIL reference panel is highly diverse and includes 261,163 participants most genetically similar to non-European reference populations, spanning 665,398,839 high-quality autosomal sites, representing a nearly 50% increase over TOPMed, the previous largest imputation service. Across multiple ancestry groups, the panel enables accurate imputation (empirical R² > 0.8) for variants with allele frequencies as low as 0.2%, extending reliable imputation into the rare-variant frequency spectrum, including allele frequencies down to 0.002% and 0.006% for samples with European ancestry and African ancestry in the United States, respectively. Compared with TOPMed, the panel improves imputation accuracy across all ancestry groups except Africans, and recovers additional trait-associated variants not represented in existing reference panels. To facilitate broad community access while preserving participant privacy, we deploy the panel through a secure cloud-based imputation platform using privacy-preserving recombined haplotypes. This resource establishes a new foundation for genome-wide association studies (GWAS) and fine-mapping, especially in previously underrepresented populations.Competing Interest StatementK.J.K. is a member of the scientific advisory board of Nurture Genomics. B.M.N is a member of the scientific advisory board at Deep Genomics, Vesalius Therapeutics, Camp4 Therapeutics, and Aluco BioSciences Inc. The remaining authors declare no competing interests.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study utilized data from participants aggregated by the All of Us (AoU) and cohorts within the NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) in accordance with their respective IRB approvals.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data are or will be available through the All of Us Researcher Workbench or the NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) under controlled access. https://allofus-anvil-imputation.broadinstitute.org/ National Human Genome Research Institute, R01HG014458, 5U24HG010262, 5U24HG010263, UM1HG008853, UM1HG008895, UM1HG008898, UM1HG008901, U24HG008956National Institutes of Health, OT2OD038121, OT2OD002748, OT2OD038111, OT2OD002750National Institute of Mental Health, R37MH107649